Nalbuphine reduced uremic pruritus in hemodialysis

SAN DIEGO – The oral opioid nalbuphine was safe and significantly reduced itching intensity in hemodialysis patients with uremic pruritus, a randomized, placebo-controlled trial showed. “Uremic...

Field of Interest: Dermatology
Type: News Item

Pregnancy did not increase Hodgkin lymphoma relapse rate

Women who become pregnant while in remission from Hodgkin lymphoma were not at increased risk for cancer relapse, according to an analysis of data from Swedish health care registries combined with...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.